Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography

Radiology

Volumn 200, Issue 3, 1996, Pages 785-792

  Senéterre, Eric ^a   Taourel, Patrick ^a   Bouvier, Yves ^a   Pradel, Jean ^a   Van Beers, Bernard ^b   Daures, Jean Pierre ^c   Pringot, Jacques ^b   Mathieu, Didier ^d   Bruel, Jean Michel ^a  

^a HÔPITAL SAINT ELOI   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c Hopital Gaston Doumergue   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Computed tomography (CT), comparative studies; Iron; Liver neoplasms, CT; Liver neoplasms, MR; Magnetic resonance (MR), comparative studies; Magnetic resonance (MR), contrast enhancement; Portography

Indexed keywords

MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAARTERIAL DRUG ADMINISTRATION; LIVER ARTERIOGRAPHY; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; PORTAL PHLEBOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 0029808352     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.3.8756932     Document Type: Article

References (38)

1. Hughes KS, Simon RM, Songhrabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1987; 103:278-288.
2. Nordlinger B, Jaeck D, Guiguet M, et al. Surgical resection of hepatic metastases: multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D, eds. Treatment of hepatic metastases of colorectal cancer. Paris, France: Springer, 1992; 129-146.
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Sure 1995; 19:59-71.
4. Sugarbaker PH. Surgical decision-making for large bowel cancer metastatic to the liver. Radiology 1990; 174:621-626.
5. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989; 172:27-34.
6. Heiken JP, Weyman PJ, Lee LKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989; 171:47-51.
7. Soyer P, Levesque M, Elias D, Zeitoun G, Roche A. Detection of liver metastases from colorectal cancer: comparison of intraoperative ultrasound and CTAP. Radiology 1992; 183:531-544.
8. Soyer P, Levesque M, Caudron C, Elias D, Zeitoun G, Roche A. MRI of liver metastases from colorectal cancer vs CT during arterial portography. J Comput Assist Tomogr 1993; 17:67-74.
9. Soyer P, Bluemke DA, Fishman EK. CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when and why. AJR 1994; 163:1325-1331.
10. Peterson MS, Baron RL, Dodd GD III, et al. Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. Radiology 1992; 185:149-155.
11. Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK. Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. Radiology 1994; 193:71-74.
12. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193:593-595.
13. Charnley RM, Morris DL, Dennison AR, Amar SS, Hardcastle JD. Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg 1991; 78:45-48.
14. Soyer P, Elias D, Zeitoun G, Roche A, Levesque M. Surgical treatment of hepatic metastases: impact of intraoperative ultrasound. AJR 1993; 160:511-514.
15. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196:471-478.
16. Bellin MF, Souhil Z, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193:657-663.
17. Bruel JM. Superparamagnetic iron oxide for the detection of hepatic lesion with MR imaging: results of a phase 111 trial (abstr). Radiology 1993; 189(P):273.
18. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168:297-301.
19. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicentric clinical trial safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:481-488.
20. Winter TC, Freeny PC, Nghiem HV, et al. MR imaging with IV Superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. AJR 1993; 161:1191-1198.
21. Couinaud C. Le foie: études anatomiques et chirurgicales. Paris, France: Masson, 1957.
22. Soyer P. Segmental anatomy of the liver: utility of a nomenclature accepted worldwide. AJR 1993, 161:572-573.
23. Dodd GD III. An American's guide to Couinaud numbering system. AJR 1993; 161:574-575.
24. Begg CB, McNeil BJ. Assessment of radiologic test: control of bias and other design considerations. Radiology 1988; 167:565-569.
25. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21:720-723.
26. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1992; 143:29-36.
27. Metz CE. Some practical issues of the experimental design and data analysis in radiological ROC studies. Invest Radiol 1989; 24:234-245.
28. Metz CE. Quantification of failure to demonstrate statistical significance: the usefulness of confidence intervals. Invest Radiol 1993; 28:59-63.
29. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrastenhanced CT, unenhanced MR imaging, and iron-oxide enhanced MR imaging. AJR 1990; 155:763-770.
30. Vogl TJ, Hammerstingl R, Pegios W, et al. The value of liver specific Superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastases. ROFO 1994; 160:319-328.
31. Denys A, Arrivé L, Servois V, et al. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994; 193:663-669.
32. Marchal G, Hecke PV, Demaerel P, et al. Detection of liver metastases with Superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR1989; 152:771-775.
33. Rummeny EJ, Wernecke K, Saini S, et al. Comparison between high-field-strength MR imaging and CT for the screening of hepatic metastases: a receiver operating characteristic analysis. Radiology 1992; 182:879-886.
34. Yamamoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195:106-112.
35. Fretz CJ, Elizondo G, Weissleder R, Hahn PF, Stark DD, Ferrruci JT Jr. Superparamagnetic iron-oxide enhanced MR imaging: pulse sequence optimization for detection of liver cancer. Radiology 1989; 172:393-397.
36. Hamm B, Reichel M, Vogl TJ, Taupitz M. Superparamagnetic iron particles: clinical results in the MR diagnosis of liver metastases. ROFO 1994; 160:52-58.
37. Edelman RR, Siegel JB, Singer A, Dupuis K, Longmaid HE. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. AJR 1989; 153:1213-1219.
38. de Lange EE, Mugler JP III, Bosworth JE, et al. MR imaging of the liver: breath-hold T1-weighted MP-GRE compared with conventional T2-weighted SE imaging: lesion detection, localization, and characterization. Radiology 1994; 190:727-736.